A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2019-04-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects of JNJ-64565111 compared with placebo in
severely obese Type 2 Diabetes Mellitus (T2DM) participants after 12 weeks of treatment on:
the percentage change in body weight from baseline and safety and tolerability.